Philippe Bedard, MD, FRCPC

Follow Dr. Bedard:
Dr. Bedard received his medical degree from the University of Toronto where he was awarded the Cody Academic Silver Medal. He completed his Internal Medicine and Medical Oncology specialty training at the University of Toronto. He received additional fellowship training in clinical and translational breast cancer research at the Breast International Group (BIG).
 
In recognition of his research excellence, Dr. Bedard received the 2012 Career Development Award from the the Conquer Cancer Foundation of the American Society of Clinical Oncology.
Dr. Bedard has a clinical practice and a research program. His clinical practice includes the treatment of patients with breast and testicular cancers. His research program involves early phase clinical trials with novel cancer drug treatments. These emerging treatments include immunotherapy and the personalization of cancer treatment based upon the results of testing for DNA mutations within tumor cells.
 
As a member of the Steering Committee for the AACR-GENIE project, Dr. Bedard is contributing to this international data-sharing initiative, which links cancer genomic data with clinical outcomes from tens of thousands of cancer patients treated at leading international institutions.

Related Links

Ann Oncol. 2019 Jan 18;:
Borcoman E, Kanjanapan Y, Champiat S, Kato S, Servois V, Kurzrock R, Goel S, Bedard P, Le Tourneau C
JCO Clin Cancer Inform. 2018 Dec;(2):1-12
Lewin J, Dufort P, Halankar J, O'Malley M, Jewett MAS, Hamilton RJ, Gupta A, Lorenzo A, Traubici J, Nayan M, Leão R, Warde P, Chung P, Anson Cartwright L, Sweet J, Hansen AR, Metser U, Bedard PL
JCO Clin Cancer Inform. 2018 Dec;(2):1-14
Micheel CM, Sweeney SM, LeNoue-Newton ML, André F, Bedard PL, Guinney J, Meijer GA, Rollins BJ, Sawyers CL, Schultz N, Shaw KRM, Velculescu VE, Levy MA, AACR Project GENIE Consortium
J Mol Diagn. 2018 Dec 18;:
Sukhai MA, Misyura M, Thomas M, Garg S, Zhang T, Stickle N, Virtanen C, Bedard PL, Siu LL, Smets T, Thijs G, Van Vooren S, Kamel-Reid S, Stockley TL
Eur J Cancer. 2018 Dec 06;107:1-7
Kanjanapan Y, Day D, Butler MO, Wang L, Joshua AM, Hogg D, Leighl NB, Razak ARA, Hansen AR, Boujos S, Chappell M, Chow K, Sherwin B, Stayner LA, Soultani L, Zambrana A, Siu LL, Bedard PL, Spreafico A
Urol Oncol. 2018 Nov 23;:
Karim S, Wei X, Leveridge MJ, Siemens DR, Robinson AG, Bedard PL, Booth CM
Nature. 2018 Nov 14;:
Shen SY, Singhania R, Fehringer G, Chakravarthy A, Roehrl MHA, Chadwick D, Zuzarte PC, Borgida A, Wang TT, Li T, Kis O, Zhao Z, Spreafico A, Medina TDS, Wang Y, Roulois D, Ettayebi I, Chen Z, Chow S, Murphy T, Arruda A, O'Kane GM, Liu J, Mansour M,...
Am Soc Clin Oncol Educ Book. 2018 May 23;(38):56-64
Kratz J, Burkard M, O'Meara T, Pusztai L, Veitch Z, Bedard PL
Ann Oncol. 2018 Aug 21;:
Mateo J, Chakravarty D, Dienstmann R, Jezdic S, Gonzalez-Perez A, Lopez-Bigas N, Ng CKY, Bedard PL, Tortora G, Douillard JY, Van Allen EM, Schultz N, Swanton C, André F, Pusztai L
BMC Med Genomics. 2018 Aug 09;11(1):65
Stjepanovic N, Stockley TL, Bedard PL, McCuaig JM, Aronson M, Holter S, Semotiuk K, Leighl NB, Jang R, Krzyzanowska MK, Oza AM, Gupta A, Elser C, Ahmed L, Wang L, Kamel-Reid S, Siu LL, Kim RH

Pages


 

Associate Professor, Faculty of Medicine, University of Toronto
Member, Steering Committee, American Association for Cancer Research (AACR) Genomics, Evidence, Neoplasia, Information, Exchange (GENIE) Project
Staff Medical Oncologist, Division of Medical Oncology, Princess Margaret Cancer Centre
Fellowship Director, Bras Drug Development Program, Princess Margaret Cancer Centre
Clinical Director, Cancer Genomics Program, Princess Margaret Cancer Centre